Millennium Medical Publishing, Inc

SHERPA: Unknown

People

  1. Horwitz
    Horwitz
  2. Slovin
    Slovin
  3. Zelenetz
    Zelenetz
  4. Berman
    Berman
  5. Falchi
    Falchi
  6. Giralt
    Giralt
  7. Grisham
    Grisham
  8. Ilson
    Ilson
  9. Korde
    Korde
  10. Ku
    Ku

Groups

  1. Department of Medicine (53)
  2. Hematologic Malignancies, Division of (53)
  3. Center for Hematologic Malignancies (35)
  4. Lymphoma (18)
  5. Adult Leukemia (11)
  6. Population Sciences Research Program (11)
  7. Hematologic Malignancies Research (4)
  8. Solid Tumor Oncology Division (4)
  9. GSK Faculty (3)
  10. Survivorship Research (3)
Search Within
  1. "Hematologic Malignancies, Division of"
Formats
  1. Journal Article (43)
  2. Review (4)
  3. Editorial (3)
  4. Miscellaneous (3)
Groups
  1. Department of Medicine (53)
  2. Hematologic Malignancies, Division of (53)
  3. Center for Hematologic Malignancies (35)
  4. Lymphoma (18)
  5. Adult Leukemia (11)
  6. Population Sciences Research Program (11)

More Groups

People
  1. Steven Horwitz (11)
  2. Craig Moskowitz (9)
  3. Dan Douer (4)
  4. Anthony Mato (3)
  5. Andrew Zelenetz (2)
  6. Carl Landgren (2)

More People

Years
  1. 2024 (2)
  2. 2022 (2)
  3. 2021 (3)
  4. 2020 (4)
  5. 2019 (2)
  6. 2018 (2)

More Years

Publications
  1. Clinical Advances in Hematology & Oncology (53)

Results (53)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A closer look at tazemetostat
    Miscellaneous

    Batlevi, C. L.
    Clinical Advances in Hematology & Oncology (2020)

    Fulltext@MSK | Save
  • Delaying the use of high-dose melphalan with stem cell rescue in multiple myeloma is ready for prime time
    Review

    Kazandjian, D.; Landgren, O.
    Clinical Advances in Hematology & Oncology (2019)

    Fulltext@MSK | Save
  • A new target in CTCL: Treating the skin, blood, and lymph nodes [interview]
    Journal Article

    Horwitz, S. M.
    Clinical Advances in Hematology & Oncology (2019)

    Fulltext@MSK | Save
  • Highlights in lymphoma from the 2017 American Society of Hematology Meeting: Commentary
    Journal Article

    Moskowitz, C. H.
    Clinical Advances in Hematology & Oncology (2018)

    Fulltext@MSK | Save
  • Checkpoint inhibition in lymphoma
    Journal Article

    Shah, G. L.; Moskowitz, C. H.
    Clinical Advances in Hematology & Oncology (2018)

    Fulltext@MSK | Save
  • Highlights in lymphoma from the 2017 ASCO meeting and the 14th ICML: Commentary
    Journal Article

    Moskowitz, C. H.
    Clinical Advances in Hematology & Oncology (2017)

    Fulltext@MSK | Save
  • Highlights in lymphoma from the 2016 American Society of Hematology Annual Meeting and Exposition: Commentary
    Journal Article

    Horwitz, S. M.
    Clinical Advances in Hematology & Oncology (2017)

    Fulltext@MSK | Save
  • Novel approaches for the interim management of relapsed/refractory acute lymphocytic leukemia: A case-study compendium
    Journal Article

    Wang, E. S.; Jabbour, E. J.; Douer, D.
    Clinical Advances in Hematology & Oncology (2016)

    Fulltext@MSK | Save
  • CD19-targeted CAR T cells as novel cancer immunotherapy for relapsed or refractory B-cell acute lymphoblastic leukemia
    Journal Article

    Davila, M. L.; Brentjens, R. J.
    Clinical Advances in Hematology & Oncology (2016)

    Fulltext@MSK | Save
  • Consolidation therapy after autologous stem cell transplant in relapsed/refractory Hodgkin lymphoma [interview]
    Journal Article

    Moskowitz, C. H.
    Clinical Advances in Hematology & Oncology (2016)

    Fulltext@MSK | Save

    • Millennium Medical Publishing, Inc – authorized name for: